Related Experiment Video
Updated: Mar 30, 2026

08:06
Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model
Published on: August 4, 2017
11.9K
Adipose Derived Regenerative Cell Therapy for Treating a Diabetic Wound: A Case Report
Wounds : a Compendium of Clinical Research and Practice
|November 20, 2015
Summary
Adipose-derived regenerative cells (ADRC) therapy successfully healed a diabetic foot wound. This groundbreaking treatment offers a promising new approach for managing complex diabetic ulcers.
Area of Science:
- Regenerative Medicine
- Wound Healing
- Diabetic Complications
Background:
- Diabetic foot ulcers represent a significant clinical challenge.
- Adipose-derived regenerative cells (ADRC) show potential in wound healing.
- This study reports the first successful ADRC application for a diabetic foot wound.
Purpose of the Study:
- To evaluate the efficacy of autologous adipose-derived regenerative cells (ADRC) therapy in treating a severe diabetic foot wound.
- To document the application and outcomes of ADRC therapy in a patient with resistant diabetic ulcers.
Main Methods:
- A patient with a necrotic diabetic foot wound underwent debridement and Chopart's amputation.
- Post-operative heel and incision site ulcers were treated with autologous ADRC-enriched fat grafting.
- ADRCs were generated using the Celusion System and applied to the wound bed and edges.
Main Results:
- Accelerated wound healing was observed post-ADRC treatment.
- Complete ulcer healing was achieved within 4 weeks.
- The ADRC therapy facilitated the restoration of deficient glabrous tissue.
Conclusions:
- ADRC therapy is a promising new treatment for diabetic foot wounds.
- This case highlights the potential of regenerative cell therapy in managing complex diabetic ulcers.
- Further research is warranted to explore ADRC therapy's broader application in wound management.

